We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

92 hedge funds and large institutions have $375M invested in Arcus Biosciences in 2020 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 26 increasing their positions, 26 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

225% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 8

37% more capital invested

Capital invested by funds: $274M → $375M (+$101M)

23% more funds holding

Funds holding: 75 → 92 (+17)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

0% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 26

0.37% less ownership

Funds ownership: 59.1% → 58.73% (-0.37%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $8K

Holders
92
Holders Change
+17
Holders Change %
+22.67%
% of All Funds
2.03%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
26
Increased
26
Reduced
26
Closed
8
Calls
–
Puts
$8K
Net Calls
-$8K
Net Calls Change
-$21K

Top Buyers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
+$17.6M
2
PHS
PFM Health Sciences
California
+$10.1M
3
Franklin Resources
Franklin Resources
California
+$5.66M
4
Millennium Management
Millennium Management
New York
+$3.77M
5
Invesco
Invesco
Georgia
+$3.56M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$44M
2
EC
EcoR1 Capital
California
-$5.44M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$2.99M
4
BlackRock
BlackRock
New York
-$2.84M
5
JP Morgan Chase
JP Morgan Chase
New York
-$999K
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
76
BNP Paribas Financial Markets
France
$139K +$26.6K +2,139 +27%
Victory Capital Management
77
Victory Capital Management
Texas
$134K +$121K +9,692 New
Citigroup
78
Citigroup
New York
$133K +$298 +24 +0.3%
MWNA
79
Marshall Wace North America
New York
$116K +$104K +8,331 New
PCM
80
Prelude Capital Management
New York
$116K +$104K +8,392 New
Legal & General Group
81
Legal & General Group
United Kingdom
$69K -$21K -1,685 -25%
Morgan Stanley
82
Morgan Stanley
New York
$45K -$516K -41,495 -93%
MAM
83
Meeder Asset Management
Ohio
$45K +$23.7K +1,906 +151%
Acadian Asset Management
84
Acadian Asset Management
Massachusetts
$42K +$37.7K +3,033 New
AIP
85
Ameritas Investment Partners
Nebraska
$35K – – –
Marshall Wace
86
Marshall Wace
United Kingdom
$35K +$31.7K +2,549 New
Osaic Holdings
87
Osaic Holdings
Arizona
$11K +$9.82K +790 New
Bank of Montreal
88
Bank of Montreal
Ontario, Canada
$6K -$49.8K -4,005 -90%
Canada Life
89
Canada Life
Manitoba, Canada
$6K – – –
CG
90
Cutler Group
California
$4K +$3.73K +300 New
Royal Bank of Canada
91
Royal Bank of Canada
Ontario, Canada
$2K -$39.3K -3,158 -95%
LC
92
Lindbrook Capital
California
$1K – – –
Janus Henderson Group
93
Janus Henderson Group
United Kingdom
– -$2.99M -296,000 Closed
D.E. Shaw & Co
94
D.E. Shaw & Co
New York
– -$334K -33,100 Closed
AC
95
Athanor Capital
New York
– -$266K -26,300 Closed
Squarepoint
96
Squarepoint
New York
– -$242K -23,911 Closed
Russell Investments Group
97
Russell Investments Group
United Kingdom
– -$207K -20,600 Closed
Tudor Investment Corp
98
Tudor Investment Corp
Connecticut
– -$136K -13,423 Closed
ACM
99
Anfield Capital Management
California
– -$76K -8,041 Closed
APA
100
American Portfolios Advisors
New York
– -$2.52K -250 Closed
1 2 3
4

RCUS Hedge Fund Activity: Q1 2020 in Review

92 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q1 2020, worth a combined $375M — up 37% from $274M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new RCUS positions and 8 closed out — a net gain of 18 holders — while 26 added to existing stakes and 26 trimmed.

The largest buyer was Boxer Capital, adding an estimated $17.6M. The largest seller was BVF Inc, cutting an estimated $44M.

  • 92 institutional investors held Arcus Biosciences (RCUS) as of Q1 2020, up from 75 in Q4 2019.
  • Funds reported $375M of Arcus Biosciences stock for Q1 2020, up 37% quarter-over-quarter.
  • 26 funds opened new Arcus Biosciences positions in Q1 2020 and 8 closed out, a net change of +18 holders.
  • The largest Arcus Biosciences buyer in Q1 2020 was Boxer Capital, an estimated $17.6M added.
  • The largest Arcus Biosciences seller in Q1 2020 was BVF Inc, an estimated $44M sold.

Based on aggregated 13F filings for Q1 2020.